- Tytuł :
- Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
- Autorzy :
- Źródło :
- In The Lancet Oncology December 2019 20(12):1655-1669
-
Czasopismo naukowe